Page last updated: 2024-10-27

flufenamic acid and Granulomatous Disease, Chronic

flufenamic acid has been researched along with Granulomatous Disease, Chronic in 1 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domínguez-Luis, M1
Herrera-García, A1
Arce-Franco, M1
Armas-González, E1
Rodríguez-Pardo, M1
Lorenzo-Díaz, F1
Feria, M1
Cadenas, S1
Sánchez-Madrid, F1
Díaz-González, F1

Other Studies

1 other study available for flufenamic acid and Granulomatous Disease, Chronic

ArticleYear
Superoxide anion mediates the L-selectin down-regulation induced by non-steroidal anti-inflammatory drugs in human neutrophils.
    Biochemical pharmacology, 2013, Jan-15, Volume: 85, Issue:2

    Topics: ADAM Proteins; ADAM17 Protein; Adolescent; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Co

2013